We're unable to sign you in at this time. Please try again in a few minutes.
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
JAMA Patient Page |

Cancer Chemotherapy FREE

John L. Zeller, MD, PhD, Writer; Cassio Lynm, MA, Illustrator; Richard M. Glass, MD, Editor
JAMA. 2008;299(22):2706. doi:10.1001/jama.299.22.2706.
Text Size: A A A
Published online

Cancer chemotherapy is the use of drugs to destroy cancer cells. Chemotherapy is usually prescribed by oncologists (physicians with advanced training in treatment of cancer). The June 11, 2008, issue of JAMA includes an article assessing the difficult decisions cancer patients and their doctors must make about the use and extent of chemotherapy as patients near the end of life.


The type of cancer, what organs are affected, age, health, and the goals and adverse effects of treatment are important issues. One of the most important issues is your "performance status," rated on the following scale. Patients with a performance status of 3 or 4 usually should not receive chemotherapy because they will have little chance of benefit and more adverse effects.

  • 0 Fully active

  • 1 Restricted in physically strenuous activity but ambulatory (able to walk) and able to carry out work of a light or sedentary nature, such as light housework or office work

  • 2 Ambulatory and capable of all self-care but unable to carry out any work activities; up and about more than 50% of waking hours

  • 3 Capable of only limited self-care; confined to bed or chair more than 50% of waking hours

  • 4 Completely disabled; cannot carry on any self-care; totally confined to bed or chair



•  What is my performance status?

•  What is my chance of cure?

•  What is the chance that this chemotherapy will make my cancer shrink?

•  Will I live longer with chemotherapy? How much longer?

•  What are the main adverse effects of the chemotherapy?

•  Will I feel better or worse from the chemotherapy?

•  Are there nonchemotherapy options such as hospice or palliative care?

•  Are there clinical trials available?

   •  What are the benefits?

   •  Am I eligible?

   •  What is needed to enroll?


•  What are the likely things that will happen to me?

•  How long will I live? (Ask for a range, and the most likely scenario for the period ahead, and when death might be expected.)

•  Are there other things I should be doing?

   •  Will

   •  Advance directives

   •  Durable attorney for health care (Who can speak for me if I am unable?)

   •  Financial or legal issues

   •  Family issues (Will you help me talk with my family?)

   •  Spiritual and psychological issues (Who is available to help me cope with this situation?)

   •  Legacy and life review (What do I want to pass on to my family about my life?)



To find this and previous JAMA Patient Pages, go to the Patient Page link on JAMA's Web site at http://www.jama.com. Many are available in English and Spanish. A Patient Page on clinical trials was published in the June 9, 2004, issue; and one on radiation therapy was published in the September 14, 2005, issue.

Sources: American Cancer Society, National Cancer Institute

The JAMA Patient Page is a public service of JAMA. The information and recommendations appearing on this page are appropriate in most instances, but they are not a substitute for medical diagnosis. For specific information concerning your personal medical condition, JAMA suggests that you consult your physician. This page may be photocopied noncommercially by physicians and other health care professionals to share with patients. To purchase bulk reprints, call 312/464-0776.





Also Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
Please click the checkbox indicating that you have read the full article in order to submit your answers.
Your answers have been saved for later.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.


Spanish Patient Pages
Supplemental Content

Some tools below are only available to our subscribers or users with an online account.

0 Citations

Related Content

Customize your page view by dragging & repositioning the boxes below.

Articles Related By Topic
Related Collections
PubMed Articles

Care at the Close of Life: Evidence and Experience
The Role of Chemotherapy at the End of Life: "When Is Enough, Enough?"

Care at the Close of Life: Evidence and Experience
Chemotherapy and Hormonal Therapy